Acute Pyelonephritis

Detailed Overview

The infection almost always begins in the bladder (cystitis) and ascends via the ureters to the kidneys. The invading bacteria attach to the uroepithelium, triggering an intense local inflammatory response. This response involves neutrophil infiltration of the renal interstitium and tubules, causing localized edema and microscopic abscesses. Clinically, it is differentiated from simple lower UTIs by the presence of systemic signs like fever, chills, and flank pain. It is broadly categorized into uncomplicated (occurring in healthy, non-pregnant premenopausal women) and complicated (occurring in men, pregnant women, or patients with structural/functional abnormalities, immunosuppression, or indwelling catheters).

Epidemiology & Demographics

Incidence in the US is approximately 15-17 cases per 10,000 females and 3-4 cases per 10,000 males annually. Highest incidence is in young sexually active women, followed by infants and older adults.

Etiological Mechanism

Escherichia coli is the overwhelmingly predominant pathogen, causing 70-80% of uncomplicated cases. Other uropathogens include Klebsiella pneumoniae, Proteus mirabilis, and Staphylococcus saprophyticus. In complicated cases, Enterococcus species, Pseudomonas aeruginosa, and extended-spectrum beta-lactamase (ESBL) producers are more common.

Primary Causes

Ascending infection from the bladder (E. coli)

Hematogenous spread (rare, usually Staphylococcus aureus bacteremia)

Vesicoureteral reflux (VUR)

Obstructive uropathy (e.g., nephrolithiasis, BPH)

• Female Anatomy: Shorter urethra and proximity to the perianal area facilitate bacterial colonization.
• Sexual Activity: Increases introduction of bacteria into the urethra.
• Urinary Tract Obstruction: Kidney stones or enlarged prostate cause urinary stasis, promoting bacterial growth.
• Diabetes Mellitus: Glycosuria promotes bacterial growth, and neuropathy can cause incomplete bladder emptying.

1. Uropathogenic E. coli colonize the periurethral area and ascend into the bladder. 2. P-fimbriae on E. coli bind to uroepithelial P-antigen receptors, preventing washout during voiding. 3. Bacteria ascend the ureters (facilitated by bacterial endotoxins inhibiting ureteral peristalsis) into the renal pelvis. 4. Infection enters the renal medulla and cortex, inducing an acute suppurative inflammatory response. 5. Neutrophils aggregate in collecting ducts and interstitial tissue, creating microabscesses. 6. Pro-inflammatory cytokines (IL-6, TNF-alpha) enter the bloodstream, causing systemic symptoms (fever, chills).

Characteristic Clinical Presentation

• Flank Pain: Unilateral or bilateral severe, aching pain in the costovertebral area due to renal capsule distension.
• Fever and Chills: Often high-grade (>38.5°C / 101.3°F) with rigors, indicating systemic involvement.
• Lower Urinary Tract Symptoms: Dysuria, frequency, and urgency may precede or accompany the systemic symptoms.
• Nausea and Vomiting: Systemic toxicity and autonomic reflex pathways frequently cause gastrointestinal upset.

Physical Examination Signs

• Costovertebral Angle (CVA) Tenderness
• Tachycardia

• Renal Abscess: Coalescence of microabscesses into a large suppurative cavity requiring drainage.
• Emphysematous Pyelonephritis: A life-threatening necrotizing infection characterized by gas production in the renal parenchyma, usually in diabetics.
• Sepsis / Septic Shock: Systemic bacterial dissemination leading to hypotension and multiorgan failure.

Diagnostic Criteria & Guidelines

Clinical diagnosis based on classic triad (fever, flank pain, CVA tenderness) supported by urinalysis demonstrating pyuria and bacteriuria. Urine culture is required to confirm the pathogen and susceptibility.

Differential Diagnosis

• Nephrolithiasis (Kidney Stones)
• Pelvic Inflammatory Disease (PID)
• Acute Appendicitis (for right-sided pain)
• Acute Cholecystitis

Laboratory Tests & Biomarkers

• Urinalysis: Positive for leukocyte esterase, nitrites (if Enterobacteriaceae), >10 WBC/hpf, and characteristic WBC casts indicating renal tubular origin of inflammation.
• Urine Culture: Growth of ≥ 10^4 CFU/mL of a uropathogen.
• Complete Blood Count: Leukocytosis with a left shift (increased band neutrophils).

Imaging Modalities & Findings

• CT Abdomen/Pelvis without contrast: Not needed routinely. Indicated if no improvement in 48-72h, checking for abscess, focal tissue hypoperfusion (striated nephrogram), or obstructing stone.
• Renal Ultrasound: Used in pregnant patients or to quickly rule out hydronephrosis/obstruction.

• Uncomplicated
  Infection in a healthy, non-pregnant adult female with normal urinary anatomy.
• Complicated
  Infection associated with factors increasing risk of failure (e.g., obstruction, stones, male sex, immunosuppression, diabetes).

Second-Line & Adjunctive Therapy

For severe or complicated cases requiring hospitalization: IV antibiotics such as Ceftriaxone 1g IV daily OR Piperacillin-tazobactam 3.375g IV q6h. Step down to oral therapy once afebrile for 24-48 hours.

Surgical & Procedural Management

Generally medical. Urology intervention (ureteral stent placement or percutaneous nephrostomy) is required emergently if pyelonephritis occurs secondary to an obstructing kidney stone.

Recommended Lifestyle Changes

• Maintain adequate hydration (2-3 liters/day) to flush the urinary tract.
• Urinate promptly after sexual intercourse.

Patient Counseling & Advice

Emphasize completing the entire antibiotic course even if feeling better to prevent recurrence or resistance. Instruct to return if fever persists > 48 hours on antibiotics or if vomiting prevents keeping oral pills down.

Follow-Up & Monitoring Schedule

Clinical reassessment in 48-72 hours if no improvement. Repeat urine culture is not routinely needed post-treatment if symptoms fully resolve.

Preventive Strategies

For recurrent cases, continuous low-dose prophylactic antibiotics (e.g., Nitrofurantoin 50 mg daily) or post-coital prophylaxis may be considered.

Excellent with prompt and appropriate antibiotic therapy. Symptoms typically improve significantly within 48-72 hours. Mortality is low except in cases of septic shock or emphysematous pyelonephritis.